Deepbridge Capital

Deepbridge Capital is a UK specialist fund manager based in Chester that leverages the EIS framework to provide highly targeted capital to emerging regional life sciences companies. The firm runs themed EIS portfolios across life sciences tools, biotech, and medical devices, channeling tax-efficient capital from UK retail and wealth-manager investors into early-stage science businesses. Their model is portfolio-construction heavy: building diversified baskets of EIS-qualifying companies rather than concentrated bets.

Deepbridge typically invests at Seed and Series A, with checks in the $1M to $5M range, often staged across multiple tranches as milestones are met. Geographic focus is the UK, with particular density in regional life sciences clusters outside London. They commonly co-invest with university spinout funds, regional VCs, and Innovate UK grant pipelines.

Founders should ensure EIS qualification status is clearly understood and structured before engaging, as this is non-negotiable for the fund’s deployment. Expect milestone-based tranching and reporting cadence aligned with EIS investor obligations. A clean corporate structure and a credible non-dilutive grant strategy alongside the equity ask materially improves the conversation.